Compounds, formulations, and methods for treating or preventing inflammatory skin disorders

Details for Australian Patent Application No. 2005247467 (hide)

Owner Sansrosa Pharmaceutical Development, Inc.

Inventors Dejovin, Jack A.; Rossi, Thomas M.

Agent Davies Collison Cave

Pub. Number AU-B-2005247467

PCT Pub. Number WO2005/115395

Priority 10/853,585 25.05.04 US; 60/574,142 25.05.04 US

Filing date 25 May 2005

Wipo publication date 8 December 2005

Acceptance publication date 2 December 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/74 (2006.01) - Synthetic polymeric materials

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2005/115395 Priority application(s): WO2005/115395

2 December 2010 Application Accepted

  Published as AU-B-2005247467

17 February 2011 Assignment before Grant

  Sansrosa Pharmaceutical Development, Inc. The application has been assigned to Galderma Pharma S.A.

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247468-A Method of and System for Distributing Secure Items

2005247466-System and method for playing a roleplaying game